Scott D. Grimes - 23 Jun 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Issuer symbol
CDLX
Transactions as of
23 Jun 2021
Transactions value $
-$251,579
Form type
4
Filing time
24 Jun 2021, 17:15:52 UTC
Previous filing
17 Jun 2021
Next filing
06 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Sale -$12.4K -100 -0.04% $123.64* 243K 23 Jun 2021 Direct F1
transaction CDLX Common Stock Sale -$127K -1.01K -0.42% $125.35* 242K 23 Jun 2021 Direct F1, F2
transaction CDLX Common Stock Sale -$75.9K -601 -0.25% $126.31* 241K 23 Jun 2021 Direct F1, F3
transaction CDLX Common Stock Sale -$36.2K -285 -0.12% $127.01* 241K 23 Jun 2021 Direct F1, F4
holding CDLX Common Stock 77.1K 23 Jun 2021 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.84 to $125.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), and (4) to this Form 4.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $125.87 to $126.71, inclusive.
F4 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $126.90 to $127.08, inclusive.
F5 The reportable securities are held by the 2013 Scott Grimes GRAT UAD.